Caris Life Sciences

Company Snapshot

Founded: 2008

Entity Type: Public

Employees: 1,846

Region: U.S.

Revenue: $812.0 Millions

Revenue Year: 2025

Headquarter: Texas, U.S.

Key Geographics: U.S., Europe, Asia

Corporate Address: 750 W. John Carpenter Freeway, Suite 800, Irving, Texas 75039, U.S. Tel.: +1-866-771-8946 Web.: www.carislifesciences.com

Company Overview

Caris Life Sciences is a precision oncology and AI TechBio company that provides comprehensive molecular profiling and data-driven insights to support cancer diagnosis, therapy selection, and drug development. In oncology, it offers tissue-based MI Profile assays and the Caris Assure liquid biopsy platform, which perform pan-cancer whole-exome and whole-transcriptome analysis of over 23,000 genes to guide targeted therapy, immunotherapy, and clinical trial matching across solid tumors and hematologic malignancies. It serves hospital and reference laboratories, community oncology networks, academic cancer centers, and life-science companies, primarily in the U.S., with an expanding presence across Europe and Asia-Pacific.

Financial Highlights (FY 2025)

Net Revenue: ***

Total Current Liabilities: ***

Total Current Assets: ***

R&D expenses: ***

Operating Income: ***

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member